COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 1585: Articles 15841-15850  | Next

Making sense of non-randomized comparative treatment studies in times of Covid-19: A case study of tocilizumab
Owen, R. R. C., Qizilbash, N., Diaz, S. V., Vazquez, J. M. C., Pocock, S. J.
10.1101/2021.04.06.21254612 — Posted: 2021-04-07
Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
Agha, M., Blake, M., Chilleo, C., Wells, A., Haidar, G.
10.1101/2021.04.06.21254949 — Posted: 2021-04-07 Discussion: Onsite
The impact of the COVID-19 pandemic on gastrointestinal infection trends in England, February - July 2020
Love, N. K., Elliot, A. J., Chalmers, R., Douglas, A., Gharbia, S., McCormick, J., Hughes, H., Morbey, R., Vivancos, R., Smith, G.
10.1101/2021.04.06.21254174 — Posted: 2021-04-07
Controlling multiple COVID-19 epidemic waves: an insight from a multi-scale model linking the behavior change dynamics to the disease transmission dynamics
Tang, B., Zhou, W., Wang, X., Wu, H., Xiao, Y., Tang, S.
10.1101/2021.04.07.21255056 — Posted: 2021-04-07
Impaired Humoral and Cellular Immunity after SARS-CoV2 BNT162b2 (Tozinameran) Prime-Boost Vaccination in Kidney Transplant Recipients
Sattler, A., Schrezenmeier, E., Weber, U., Potekhin, A., Bachmann, F., Budde, K., Storz, E., Pross, V., Bergmann, Y., Thole, L., Tizian, C., Hoelsken, O., Diefenbach, A., Schrezenmeier, H., Jahrsdoerfer, B., Zemojtel, T., Jechow, K., Conrad, C., Lukassen, S., Stauch, D., Lachmann, N., Choi, M., Halleck, F., Kotsch, K.
10.1101/2021.04.06.21254963 — Posted: 2021-04-07
It's possibly made us feel a little more alienated: How people from ethnic minority communities conceptualise COVID-19 and its influence on engagement with testing.
Vandrevala, T. F., Alidu, L., Hendy, J., Shafi, S., Ala, A.
10.1101/2021.04.06.21254961 — Posted: 2021-04-07
Impacts of Morally Distressing Experiences on the Mental Health of Canadian Health Care Workers During the COVID-19 Pandemic
Plouffe, R. A., Nazarov, A., Forchuk, C. A., Gargala, D., Deda, E., Le, T., Bourret-Gheysen, J., Jackson, B., Soares, V., Hosseiny, F., Smith, P., Roth, M., MacDougall, A. G., Marlborough, M., Jetly, R., Heber, A., Albuquerque, J., Lanius, R., Balderson, K., Dupuis, G., Mehta, V., Richardson, J. D.
10.1101/2021.04.06.21254800 — Posted: 2021-04-07
COVID-19 Time-varying Reproduction Numbers Worldwide: An Empirical Analysis of Mandatory and Voluntary Social Distancing
Chudiik, A., Pesaran, M. H., Rebucci, A.
10.1101/2021.04.06.21255033 — Posted: 2021-04-07
Statistical Modeling of deaths due to COVID-19 influenced by social isolation in Latin American countries
Silva, R. A. d., Ferreira, L. P. d. S., Sampaio Leite, J. M. R., Tiraboschi, F. A., Valente, T. M., Roda, V. M. d. P., Sanchez, J. J. D.
10.1101/2021.04.05.21254941 — Posted: 2021-04-07 Discussion: Onsite
Single Prime hAd5 Spike (S) + Nucleocapsid (N) Dual Antigen Vaccination of Healthy Volunteers Induces a Ten-Fold Increase in Mean S- and N- T-Cell Responses Equivalent to T-Cell Responses from Patients Previously Infected with SARS-CoV-2
Sieling, P., King, T., Wong, R., Nguyen, A., Wnuk, K., Gabitzsch, E. R., Rice, A., Adisetiyo, H., Hermreck, M., Verma, M., Zakin, L., Shin, A., Morimoto, B., Higashide, W., Dinkins, K., Balint, J., Peykov, V., Taft, J., Patel, R., Buta, S., Martin-Fernandez, M., Bogunovic, D., Spilman, P., Sender, L., Reddy, S., Robinson, P., Rabizadeh, S., Niazi, K., Soon-Shiong, P.
10.1101/2021.04.05.21254940 — Posted: 2021-04-07 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).